Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity

Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity

Purpose: The authors report three separate cases of type 1 retinopathy of prematurity (ROP) treated with intravitreal bevacizumab before, or at 34 weeks postmenstrual age (PMA), with subsequent development of secondary glaucoma. Observations: All three cases involve patients born ≤24 weeks and meeti...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony A. Jones, Jacob S. Martin, Annette L. Giangiacomo, Deborah M. Costakos
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Avastin
Bevacizumab
Secondary glaucoma
Retinopathy of prematurity
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993624001415
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items